Through use of anti-IL1β monoclonal antibodies, Nie et al. demonstrated that PDT stimulates a local inflammatory response in cancer cells through activation of NLRP3 inflammosome with synergistic IL1β production from CAFs. Here, IL1B is linked to cancer.